# Bone Density Basics

## Overview

DEXA technology is used for both body composition analysis and bone mineral density (BMD) measurement, but these are different scans with different clinical applications. Understanding this distinction is essential for healthcare providers and educators who work with DEXA data—knowing what body composition DEXA can and cannot tell you about bone health, when to recommend clinical BMD testing, and how to communicate these differences to patients.

## Two Types of DEXA Scans

![Body composition DEXA vs. clinical BMD DEXA](/content/assets/diagrams/bmd-vs-body-comp-dexa.png)

Both scan types use the same underlying technology—dual-energy X-ray absorptiometry—but they serve fundamentally different purposes.

### Body Composition DEXA (What BodySpec Provides)

A body composition DEXA scan measures fat mass, lean mass, and bone mineral content across the entire body from head to toe. The output includes body fat percentage, lean mass, regional breakdown, VAT estimation, and total bone mineral content (BMC). For bone specifically, it provides total body bone mineral content in grams along with an age/sex percentile ranking. This scan is designed for comprehensive body composition assessment and is not intended for diagnosing osteoporosis or guiding osteoporosis treatment.

### Clinical BMD DEXA (Medical Bone Density)

A clinical BMD scan serves a different purpose: screening for and diagnosing osteoporosis and assessing fracture risk. Rather than scanning the whole body, it focuses on the lumbar spine (L1-L4) and proximal femur (femoral neck and total hip)—the sites most vulnerable to osteoporotic fracture. The output consists of T-scores and Z-scores at each specific site, which are used for osteoporosis diagnosis (a T-score of -2.5 or below), fracture risk assessment (FRAX score calculation), and treatment monitoring. This type of scan requires a clinical DEXA facility, a physician order, and specialized technician training.

:::warning
Body composition DEXA cannot diagnose osteoporosis. Patients concerned about bone health should be referred for site-specific clinical BMD testing at a medical facility.
:::

### Why the Difference Matters

The distinction between these two scan types has important clinical implications. Osteoporosis preferentially affects certain skeletal sites—particularly the lumbar spine and femoral neck—and whole-body BMC averages across the entire skeleton, potentially masking site-specific deficits. Clinical BMD scans use different positioning, scan modes, and analysis software optimized for the hip and spine regions. The T-score system, which compares an individual's BMD to young adult peak bone mass, is validated only for the specific sites and protocols defined by the WHO and ISCD. Osteoporosis medication prescribing guidelines are based on these site-specific T-scores, not whole-body BMC.

## What Body Composition DEXA Shows About Bone

### Total Body Bone Mineral Content

Body composition DEXA provides several bone-related measurements that offer a general picture of skeletal health. Total body BMC, expressed in grams, represents the sum of all bone mineral in the skeleton—this is a real measurement, not an estimate, and serves as a general indicator of skeletal health. Regional BMC breaks this total down by arms, legs, trunk, and head, which can identify whether certain regions have notably lower bone mineral. An age/sex percentile ranking shows how the individual's BMC compares to the reference population for their age and sex, providing useful context for interpretation.

### Useful Applications

While not diagnostic for osteoporosis, body composition BMC data serves several valuable clinical purposes. Tracking longitudinal trends is perhaps the most important: if total BMC decreases significantly over serial scans, this warrants further investigation even though the measurement itself is not diagnostic. For individuals at very low percentiles (below the 10th for age and sex), the finding may warrant referral for formal BMD testing. In populations not yet indicated for formal BMD screening, body composition BMC can flag potential concerns that might otherwise go undetected. Seeing bone data alongside body composition results also encourages patients to consider bone health as part of their overall health picture, motivating protective lifestyle changes.

### Limitations

Understanding the boundaries of body composition bone data prevents misinterpretation and ensures appropriate clinical use. T-scores cannot be calculated from whole-body scans—they are specific to clinical BMD protocols and validated only for site-specific measurements. The WHO definition of osteoporosis requires site-specific T-scores, so body composition DEXA cannot diagnose the condition. Body composition scans are optimized for soft tissue measurement, and bone precision may be lower than dedicated BMD scans. Osteoporosis medication decisions must be based on clinical BMD results, not body composition bone data. Additionally, very large or very small individuals may have BMC values that reflect body size rather than bone quality, introducing a potential confound in interpretation.

## When to Recommend Clinical BMD

### USPSTF Screening Recommendations

The United States Preventive Services Task Force (USPSTF) provides evidence-based recommendations for osteoporosis screening that guide clinical decision-making. Universal screening is recommended for women aged 65 and older. Postmenopausal women under 65 should be screened if they are at increased risk as estimated by clinical risk assessment tools. For men aged 70 and older, some guidelines recommend screening, though the USPSTF states there is insufficient evidence for universal male screening. Younger adults with specific risk factors may warrant screening regardless of age (USPSTF, 2025)[^1].

### Risk Factors Prompting Earlier Screening

Several categories of risk factors should prompt consideration of clinical BMD referral even in patients who do not yet meet age-based screening criteria. Medication history is an important consideration: prolonged corticosteroid use (more than 3 months of prednisone 5mg or equivalent), aromatase inhibitors, androgen deprivation therapy, and certain anticonvulsants all accelerate bone loss. Medical conditions including rheumatoid arthritis, celiac disease, inflammatory bowel disease, hyperthyroidism, hyperparathyroidism, type 1 diabetes, chronic kidney disease, and COPD are associated with increased fracture risk. Lifestyle factors such as current smoking, excessive alcohol use (more than 3 drinks per day), and very low body weight further elevate risk. A family history of hip fracture in a parent and a personal history of fragility fracture, height loss of more than 1.5 inches, or kyphosis are also strong indicators for earlier screening.

### From Body Composition DEXA Findings

Certain findings on body composition DEXA should prompt consideration of clinical BMD referral, even when traditional screening criteria have not been met. A very low bone mineral content percentile (below the 10th for age and sex) or unexpectedly low BMC given the individual's body size and activity level may signal underlying bone health concerns. Declining BMC on serial scans without a clear explanation warrants further investigation. Concurrent sarcopenia risk—low lean mass combined with low BMC—may indicate a systemic nutritional or hormonal deficiency affecting both muscle and bone. Post-menopausal women or older men who have not yet undergone formal osteoporosis screening represent another group where body composition bone data can serve as a valuable prompt for referral.

:::clinical
Body composition DEXA can serve as an opportunity to identify patients who should be referred for formal BMD testing but are not yet in the formal screening population. Use low BMC percentile as a prompt for conversation, not a diagnosis.
:::

## Patient Communication

### Common Questions

**"Does this scan check my bone density?"**
"This scan measures your total bone mineral content, which gives us a general picture of your bone health. It's useful for tracking changes over time. However, it's different from a clinical bone density test, which looks specifically at your spine and hip—the areas most at risk for osteoporosis-related fractures. If you're concerned about bone health or osteoporosis, I'd recommend talking to your doctor about a site-specific bone density scan."

**"My bone number seems low—do I have osteoporosis?"**
"This scan can't diagnose osteoporosis. What it shows is your total body bone mineral compared to others your age and sex. A lower number could mean many things and doesn't automatically indicate osteoporosis. If the result is concerning, it's worth discussing with your doctor, who can order the specific bone density test if needed."

**"Can I use this instead of a bone density test?"**
"No, they serve different purposes even though both use DEXA technology. Think of it like how the same camera can take a landscape photo and a close-up portrait—same technology, different applications. This scan gives you great body composition data, but osteoporosis diagnosis requires a focused scan of your hip and spine with different protocols."

**"My doctor told me to get a DEXA scan. Is this what they meant?"**
"If your doctor specifically mentioned bone density or osteoporosis screening, they likely meant a clinical BMD scan, which is different from this body composition scan. Body composition DEXA is for measuring fat, muscle, and overall bone mineral. A clinical BMD scan focuses specifically on your hip and spine for osteoporosis diagnosis. You'll want to clarify with your doctor which type they intended."

**"My bone mineral went up/down between scans. What does that mean?"**
"Small changes in total body bone mineral between scans may be within the measurement precision and not clinically significant. However, consistent trends over multiple scans are worth noting. If your bone mineral is trending downward, that's a good conversation to have with your doctor. Remember, this scan tracks overall bone health trends but isn't designed for osteoporosis diagnosis."

## Understanding the Results

### What You'll See

A typical body composition DEXA report includes several bone-related data points that provide a general picture of skeletal health. Total body bone mineral content, expressed in grams, represents the total mineral mass of the entire skeleton. An age/sex percentile ranking shows where the individual falls compared to others of the same age and sex. Regional bone mineral provides a breakdown by arms, legs, trunk, and head, which can highlight areas of relative weakness. Total body BMD (g/cm²) represents bone mineral density averaged across the entire skeleton.

### Interpreting the Numbers

Percentile rankings provide the most intuitive framework for interpreting body composition bone data. A percentile above the 25th is generally reassuring, indicating that bone mass is within the expected range. Percentiles between the 10th and 25th represent the lower end of normal—worth considering in conjunction with risk factors and whether formal screening is appropriate. A percentile below the 10th falls below the expected range and warrants a conversation about risk factors and potential referral for clinical BMD testing. Perhaps most importantly, percentile trends across serial scans carry more clinical weight than any single measurement—consistent downward movement is more concerning than an isolated low reading.

### Factors That Affect Bone Mineral Content

Multiple factors influence body composition BMC measurements, and understanding these helps contextualize individual results. Body size plays a significant role, as larger individuals generally have higher total BMC. Physical activity—particularly weight-bearing and resistance exercise—promotes bone mineral accrual. Adequate calcium, vitamin D, and protein intake support bone health through different nutritional pathways. Hormonal status is critical: estrogen in women and testosterone in men play essential roles in bone maintenance. Peak bone mass occurs around age 30, with gradual decline thereafter. Certain medications, including corticosteroids and aromatase inhibitors, can affect bone metabolism and should be considered when interpreting BMC values.

## Bone Health Optimization

### Lifestyle Factors That Support Bone Health

While body composition DEXA is not a bone health diagnostic tool, the data can motivate patients to adopt bone-protective habits. Weight-bearing exercise—including walking, jogging, dancing, and stair climbing—provides the mechanical stimulus that maintains bone density. Resistance training is particularly valuable, as it stimulates bone formation through direct mechanical loading at muscle attachment sites. Nutritional factors are equally important: adequate calcium intake (1,000-1,200 mg/day from diet and/or supplements), sufficient vitamin D (600-800 IU/day minimum, with many adults benefiting from higher doses), and adequate protein all support bone health through complementary mechanisms. Modifiable risk factors should also be addressed—excessive alcohol consumption (more than 3 drinks per day) increases fracture risk, and smoking accelerates bone loss.

### Connection to Body Composition

Bone health and body composition are deeply interconnected through several physiological mechanisms. Muscle exerts force on bone during contraction, stimulating bone formation through mechanotransduction—this is why higher lean mass is consistently associated with higher BMD. The relationship between fat mass and bone is more complex: mechanical loading from body weight supports bone density, but excessive fat (especially visceral fat) produces inflammatory cytokines that may harm bone through increased osteoclast activity. Sarcopenia and osteoporosis frequently co-occur, creating what researchers call "dysmobility syndrome"—a combination of low muscle mass and low bone density that elevates both fall risk and fracture risk simultaneously.

:::note
Interventions that build muscle (resistance training, adequate protein) also support bone health. Patients working on body composition improvement are simultaneously supporting their skeletal health.
:::

## Summary

Body composition DEXA provides valuable general information about bone mineral content, but it serves a fundamentally different purpose than clinical BMD testing for osteoporosis. Providers should understand this distinction to counsel patients appropriately: body composition bone data can identify individuals who may benefit from formal BMD screening, track longitudinal trends, and motivate bone-healthy lifestyle choices, but it cannot diagnose osteoporosis or guide osteoporosis treatment. When body composition DEXA reveals unexpectedly low or declining bone mineral, appropriate referral for site-specific clinical BMD testing ensures patients receive proper evaluation and care.

## References

[^1]: US Preventive Services Task Force. "Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement." *JAMA*. 2025;333(4):304-312. doi:10.1001/jama.2024.27154
[^2]: ISCD. "2023 Official Positions—Adult." International Society for Clinical Densitometry. Available at: https://iscd.org/official-positions-2023/
[^3]: Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. "Body composition by DXA." *Bone*. 2017;104:101-105. doi:10.1016/j.bone.2017.06.010
